Skip to main content
Clinical Trials/JPRN-UMIN000008574
JPRN-UMIN000008574
Completed
N/A

A prospective clinical study to evaluate the feasibility and safeness of the chemotherapy with weekly paclitaxel administration in cases with anaplastic thyroid cancer - ATCCJ-TXL-P2

Anaplastic Thyroid Carcinoma Consortium Japan0 sites50 target enrollmentJuly 31, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Anaplastic Thyroid Carcinoma Consortium Japan
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 31, 2012
End Date
March 31, 2015
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Anaplastic Thyroid Carcinoma Consortium Japan

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patient who matches one of these criterion. (1\) suspision for interstitial pneumonia or pulmonary fibrosis by chest radiograph (2\) brain metastasis with symptom (3\) presence of the active peptic ulcer (4\) presence of the active other malignancies (5\) fever more than 38C (6\) severe complication (e.g. myocardial infarction within 3 months, heart failure with clinically problem, poorly controlled diabetes mellitus, severe infectious disease. (7\) past history for severe drug allergy (8\) past history of hypersisitivity to polyoxyethylated or hydrogenated castor oil (9\) hypersisitivity to alcohol (10\) pregnant or nursing women (11\) difficult to entry due to psychological problem (12\) previous chemotherapy or radiation therapy to the present illness (13\) physician judged improper to entry this trial

Outcomes

Primary Outcomes

Not specified

Similar Trials